We are open as normal during COVID-19 pandemic. Order online, same day shipping out.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 522619

CAS#: 300837-31-4

Description: XCT0135908 is a RXR agonist. XCT0135908 showed selectivity for RXR−Nurr1 over a broad range of other RXR dimerization partners but with rather low potency. XCT0135908 yielded promising results in a rat neuron PD model. Note: Sci-Finder registered this compound as XCT 0315908.

Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-06-02. Prices are subject to change without notice.

XCT0135908 is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 522619
Name: XCT0135908
CAS#: 300837-31-4
Chemical Formula: C21H19N3O2
Exact Mass: 345.1477
Molecular Weight: 345.402
Elemental Analysis: C, 73.03; H, 5.54; N, 12.17; O, 9.26

Synonym: XCT0135908; XCT-0135908; XCT 0135908.

IUPAC/Chemical Name: 4-((5-allyl-6-methyl-2-phenylpyrimidin-4-yl)amino)benzoic acid


InChi Code: InChI=1S/C21H19N3O2/c1-3-7-18-14(2)22-19(15-8-5-4-6-9-15)24-20(18)23-17-12-10-16(11-13-17)21(25)26/h3-6,8-13H,1,7H2,2H3,(H,25,26)(H,22,23,24)


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1. Preparation of 4-​amino substituted condensed pyrimidine compounds as selective PDE4 inhibitors useful in treatment of diseases
By Konetzki, Ingo; Jakob, Florian; Craan, Tobias; Hesslinger, Christian
From PCT Int. Appl. (2014), WO 2014117947 A1 20140807. | Language: English, Database: CAPLUS

2. Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
By Gurney, Mark E.; Atkins, Collen M.; Adaikkalasamy, David J.; Dietrich, W. Dalton
From U.S. Pat. Appl. Publ. (2014), US 20140121221 A1 20140501. | Language: English, Database: CAPLUS

3. Treatment of neurodegenerative diseases using retinoid X receptor (RXR)​-​selective agonists
By Burstein, Ethan S.; Olsson, Roger; McFarland, Krista
From PCT Int. Appl. (2013), WO 2013020966 A1 20130214. | Language: English, Database: CAPLUS

4. Treatment of neurodegenerative diseases using retinoid X receptor (RXR)​-​selective agonists
By Burstein, Ethan S.; Olsson, Roger; McFarland, Krista
From Eur. Pat. Appl. (2013), EP 2556827 A1 20130213. | Language: English, Database: CAPLUS

5. Discovery of selective PDE4B inhibitors
By Naganuma, Kenji; Omura, Akifumi; Maekawara, Naomi; Saitoh, Masahiro; Ohkawa, Naoto; Kubota, Takashi; Nagumo, Hiromitsu; Kodama, Toshiyuki; Takemura, Masayoshi; Ohtsuka, Yuji; et al
From Bioorganic & Medicinal Chemistry Letters (2009), 19(12), 3174-3176. | Language: English, Database: CAPLUS

6. Electrospray Mass Spectrometry for the Direct Accurate Mass Measurement of Ligands in Complex With the Retinoid X Receptor α Ligand Binding
By Lengqvist, Johan; Alvelius, Gunvor; Joernvall, Hans; Sjoevall, Jan; Perlmann, Thomas; Griffiths, William J.
From Journal of the American Society for Mass Spectrometry (2005), 16(10), 1631-1640. | Language: English, Database: CAPLUS

7. Substituted pyrimidine compositions and methods using them for the treatment of NGFI-​B-​related diseases
By Martin, Richard; Mohan, Raju; Ordentlich, Peter
From PCT Int. Appl. (2005), WO 2005047268 A2 20050526. | Language: English, Database: CAPLUS